Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Skeletal Muscle Relaxants: Adverse Effects
Desensitization and Tachyphylaxis
Decreased pulse rate
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 4, 2025

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Santiago O Valdés1, Taylor S Howard1, Tam Dan N Pham1
1Department of Pediatrics, Lillie Frank Abercrombie Section of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.
No abstract available in PubMed .